AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-80
Results: 26-50/80

Authors: DRIOUCH K CHAMPEME M BEUZELIN M BIECHE I LIDEREAU R
Citation: K. Driouch et al., CLASSICAL GENE AMPLIFICATIONS IN HUMAN BREAST-CANCER ARE NOT ASSOCIATED WITH DISTANT SOLID METASTASES, British Journal of Cancer, 76(6), 1997, pp. 784-787

Authors: BIECHE I NOGUES C RIVOILAN S KHODJA A LATIL A LIDEREAU R
Citation: I. Bieche et al., PROGNOSTIC VALUE OF LOSS OF HETEROZYGOSITY AT BRCA2 IN HUMAN BREAST-CARCINOMA, British Journal of Cancer, 76(11), 1997, pp. 1416-1418

Authors: SEROVASINILNIKOVA OM BOUTRAND L STOPPALYONNET D BRESSACDEPAILLERETS B DUBOIS V LASSET C JANIN N BIGNON YJ LONGY M MAUGARD C LIDEREAU R LEROUX D FREBOURG T MAZOYER S LENOIR GM
Citation: Om. Serovasinilnikova et al., BRCA2 MUTATIONS IN HEREDITARY BREAST AND OVARIAN-CANCER IN FRANCE, American journal of human genetics, 60(5), 1997, pp. 1236-1239

Authors: BIECHE I DEMURCIA G LIDEREAU R
Citation: I. Bieche et al., POLY(ADP-RIBOSE) POLYMERASE GENE-EXPRESSION STATUS AND GENOMIC INSTABILITY IN HUMAN BREAST-CANCER, Clinical cancer research, 2(7), 1996, pp. 1163-1167

Authors: SCHOLL S BIECHE I PALLUD C CHAMPEME MH BEUVON F HACENE K GULLICK W POUILLART P LIDEREAU R
Citation: S. Scholl et al., RELEVANCE OF MULTIPLE BIOLOGICAL PARAMETERS IN BREAST-CANCER PROGNOSIS, Breast, 5(1), 1996, pp. 21-30

Authors: BIECHE I LIDEREAU R
Citation: I. Bieche et R. Lidereau, A GENE DOSAGE EFFECT IS RESPONSIBLE FOR OVEREXPRESSION OF THE MUC1 GENE IN HUMAN BREAST-CANCER, Cytogenetics and cell genetics, 72(2-3), 1996, pp. 145-145

Authors: BIECHE I CHAMPEME MH LIDEREAU R
Citation: I. Bieche et al., LOSS AND GAIN OF DISTINCT REGIONS OF CHROMOSOME 1Q IN PRIMARY BREAST-CANCER, Cytogenetics and cell genetics, 72(2-3), 1996, pp. 145-145

Authors: SCHOLL SM LIDEREAU R DELAROCHEFORDIERE A LENIR CCS MOSSERI V NOGUES C POUILLART P STANLEY ER
Citation: Sm. Scholl et al., CIRCULATING LEVELS OF THE MACROPHAGE-COLONY-STIMULATING FACTOR CSF-1 IN PRIMARY AND METASTATIC BREAST-CANCER PATIENTS - A PILOT-STUDY, Breast cancer research and treatment, 39(3), 1996, pp. 275-283

Authors: JULIE C BIECHE Y RUFFET E LIDEREAU R FRANC B
Citation: C. Julie et al., MUC-1 MUCIN EXPRESSION IN BENIGN ADENOMAS AND PAPILLARY CARCINOMAS OFTHE THYROID, Laboratory investigation, 74(1), 1996, pp. 269-269

Authors: LATIL A FOURNIER G CUSSENOT O LIDEREAU R
Citation: A. Latil et al., DIFFERENTIAL CHROMOSOME ALLELIC IMBALANCE IN THE PROGRESSION OF HUMANPROSTATE-CANCER, The Journal of urology, 156(6), 1996, pp. 2079-2083

Authors: LATIL A CUSSENOT O FOURNIER G LIDEREAU R
Citation: A. Latil et al., THE BRCA2 GENE IS NOT RELEVANT TO SPORADIC PROSTATE TUMORS, International journal of cancer, 66(2), 1996, pp. 282-283

Authors: BIECHE I TOMASETTO C REGNIER CH MOOGLUTZ C RIO MC LIDEREAU R
Citation: I. Bieche et al., 2 DISTINCT AMPLIFIED REGIONS AT 17Q11-Q21 INVOLVED IN HUMAN PRIMARY BREAST-CANCER, Cancer research, 56(17), 1996, pp. 3886-3890

Authors: LIDEREAU R
Citation: R. Lidereau, GENETIC-MARKERS FOR PROGNOSIS AND THERAPE UTIC EFFECTS, Bulletin du cancer, 83(12), 1996, pp. 1040-1040

Authors: SHENG ZM MARCHETTI A BUTTITTA F CHAMPEME MH CAMPANI D BISTOCCHI M LIDEREAU R CALLAHAN R
Citation: Zm. Sheng et al., MULTIPLE REGIONS OF CHROMOSOME 6Q AFFECTED BY LOSS OF HETEROZYGOSITY IN PRIMARY HUMAN BREAST CARCINOMAS, British Journal of Cancer, 73(2), 1996, pp. 144-147

Authors: LATIL A CUSSENOT O FOURNIER G BARON JC LIDEREAU R
Citation: A. Latil et al., LOSS OF HETEROZYGOSITY AT 7Q31 IS A FREQUENT AND EARLY EVENT IN PROSTATE-CANCER, Clinical cancer research, 1(11), 1995, pp. 1385-1389

Authors: BIECHE I CHAMPEME MH LIDEREAU R
Citation: I. Bieche et al., LOSS AND GAIN OF DISTINCT REGIONS OF CHROMOSOME 1Q IN PRIMARY BREAST-CANCER, Clinical cancer research, 1(1), 1995, pp. 123-127

Authors: BIECHE I LIDEREAU R
Citation: I. Bieche et R. Lidereau, GENETIC ALTERATIONS IN BREAST-CANCER, Genes, chromosomes & cancer, 14(4), 1995, pp. 227-251

Authors: CHAMPEME MH BIECHE I BEUZELIN M LIDEREAU R
Citation: Mh. Champeme et al., LOSS OF HETEROZYGOSITY ON 7Q31 OCCURS EARLY DURING BREAST TUMORIGENESIS, Genes, chromosomes & cancer, 12(4), 1995, pp. 304-306

Authors: CHAMPEME MH BIECHE I LIZARD S LIDEREAU R
Citation: Mh. Champeme et al., 11Q13 AMPLIFICATION IN LOCAL RECURRENCE OF HUMAN PRIMARY BREAST-CANCER, Genes, chromosomes & cancer, 12(2), 1995, pp. 128-133

Authors: CHAMPEME MH MAZOYER S STOPPALYONNET D BIECHE I ITHIER G SOBOL H NOGUES C LIDEREAU R
Citation: Mh. Champeme et al., SUBLOCALIZATION OF SMALLEST COMMON REGIONS OF DELETION ON CHROMOSOME 17Q12-Q23 IN SPORADIC PRIMARY BREAST-TUMORS, Oncology Reports, 2(5), 1995, pp. 825-831

Authors: DRIOUCH K CHAMPEME MH BEUZELIN M BIECHE I LIDEREAU R
Citation: K. Driouch et al., CLASSICAL GENE AMPLIFICATIONS IN HUMAN BREAST-CANCER ARE NOT RESPONSIBLE OF DISTANT METASTASES, European journal of cancer, 31A, 1995, pp. 447-447

Authors: BIECHE I CHAMPEME MH LIDEREAU R
Citation: I. Bieche et al., A TUMOR-SUPPRESSOR GENE ON CHROMOSOME 1P32-PTER CONTROLS THE AMPLIFICATION OF MYC FAMILY GENES IN BREAST-CANCER, European journal of cancer, 31A, 1995, pp. 451-451

Authors: COPIGNY F CHAMPEME MH BIECHE I HACENE K LIDEREAU R
Citation: F. Copigny et al., INT-2 FGF3 AMPLIFICATION IS BETTER INDEPENDENT PREDICTOR OF RELAPSE THAN C-MYC AND C-ERBB-2/NEU AMPLIFICATIONS IN PRIMARY HUMAN BREAST-CANCER/, European journal of cancer, 31A, 1995, pp. 451-451

Authors: CHAMPEME MH BIECHE I BEUZELIN M LIDEREAU R
Citation: Mh. Champeme et al., LOSS OF HETEROZYGOSITY ON 7Q31 OCCURS EARLY DURING BREAST TUMORIGENESIS, European journal of cancer, 31A, 1995, pp. 452-452

Authors: LATIL A CUSSENOT O FOURNIER G BARON JC LIDEREAU R
Citation: A. Latil et al., LOSS OF HETEROZYGOSITY AT 7Q31 IS A FREQUENT AND EARLY EVENT IN PROSTATE-CANCER, European journal of cancer, 31A, 1995, pp. 453-453
Risultati: 1-25 | 26-50 | 51-75 | 76-80